Brief: Lipocine Announces Supply And Distribution Agreement With Pharmalink
08/10/2024 13:07
Oct 8 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE ANNOUNCES SUPPLY AND DISTRIBUTION AGREEMENT WITH
PHARMALINK TO COMMERCIALIZE TLANDO® IN THE GULF COOPERATION
COUNCIL (GCC) COUNTRIES
* LIPOCINE INC - RECEIVES UPFRONT PAYMENT FROM PHARMALINK
UNDER
AGREEMENT TERMS
* LIPOCINE INC - PHARMALINK TO HAVE EXCLUSIVE RIGHTS TO
TLANDO IN
GCC REGION
Source text for Eikon: ID:nPn7ryKQla
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy